EU Clinical Trial 2017-001611-37

A 52 week prospective randomized controlled study to investigate the effect of intramuscular testosterone undecanoate supplementation vs placebo on intrahepatic fat content in obese men with uncontrolled type 2 diabetes (T2DM) suffering from hypogonadism with a subsequent 108 week open label phase to investigate long term effects on lipid distribution and cardiometabolic parameters in all participating men.  Feb 27, 2019

Main objective of the trial: • to identify the effects of testosterone supplementation in hypogonadal men suffering from type 2 diabetes on intrahepatic fat content assessed as change from baseline to follow up


Nebido Testosterone undecanoate

JSON preview

Similar records


Source:  EMA Last updated:  May 30, 2019

From, a database of the European Medicines Agency. This record may not reflect the most current and accurate data available from the EMA.